These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 8179929

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT, Wessely O, Pironin M, Beug H, Ghysdael J.
    EMBO J; 1997 Sep 15; 16(18):5639-53. PubMed ID: 9312023
    [Abstract] [Full Text] [Related]

  • 3. Mammalian granulocyte-macrophage colony-stimulating factor receptor expressed in primary avian hematopoietic progenitors: lineage-specific regulation of proliferation and differentiation.
    Wessely O, Deiner EM, Lim KC, Mellitzer G, Steinlein P, Beug H.
    J Cell Biol; 1998 May 18; 141(4):1041-51. PubMed ID: 9585421
    [Abstract] [Full Text] [Related]

  • 4. Murine pluripotent hematopoietic progenitors constitutively expressing a normal erythropoietin receptor proliferate in response to erythropoietin without preferential erythroid cell differentiation.
    Dubart A, Feger F, Lacout C, Goncalves F, Vainchenker W, Dumenil D.
    Mol Cell Biol; 1994 Jul 18; 14(7):4834-42. PubMed ID: 8007982
    [Abstract] [Full Text] [Related]

  • 5. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
    Arcasoy MO, Maun NA, Perez L, Forget BG, Berliner N.
    Eur J Haematol; 2001 Aug 18; 67(2):77-87. PubMed ID: 11722594
    [Abstract] [Full Text] [Related]

  • 6. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O, Fusil F, Henri A, Villette JM, Leboulch P, Beuzard Y, Payen E.
    Exp Hematol; 2008 Apr 18; 36(4):412-23. PubMed ID: 18295963
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary erythroblasts.
    Dolznig H, Habermann B, Stangl K, Deiner EM, Moriggl R, Beug H, Müllner EW.
    Curr Biol; 2002 Jul 09; 12(13):1076-85. PubMed ID: 12121614
    [Abstract] [Full Text] [Related]

  • 8. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
    Shi J, Yuan B, Hu W, Lodish H.
    Exp Hematol; 2016 Nov 09; 44(11):1044-1058.e5. PubMed ID: 27473563
    [Abstract] [Full Text] [Related]

  • 9. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
    Slavova-Azmanova NS, Kucera N, Louw A, Satiaputra J, Handoko A, Singer P, Stone L, McCarthy DJ, Klinken SP, Hibbs ML, Ingley E.
    Biochem J; 2014 May 01; 459(3):455-66. PubMed ID: 24552351
    [Abstract] [Full Text] [Related]

  • 10. The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors.
    Schroeder C, Raynoschek C, Fuhrmann U, Damm K, Vennström B, Beug H.
    Oncogene; 1990 Oct 01; 5(10):1445-53. PubMed ID: 1979159
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of a truncated erythropoietin receptor for erythroid differentiation.
    Nakamura Y, Tokumoto Y, Nakauchi H.
    Biochem Biophys Res Commun; 1996 Jan 05; 218(1):205-9. PubMed ID: 8573132
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Purification and characterization of the yeast-expressed erythropoietin mutant Epo (R103A), a specific inhibitor of human primary hematopoietic cell erythropoiesis.
    Burns S, Arcasoy MO, Li L, Kurian E, Selander K, Emanuel PD, Harris KW.
    Blood; 2002 Jun 15; 99(12):4400-5. PubMed ID: 12036868
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.